L A Hammond Selected Research

9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)

12/2000

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L A Hammond Research Topics

Disease

11	Neoplasms (Cancer) 12/2004 - 01/2000
5	Diarrhea 02/2006 - 01/2000
3	Carcinoma (Carcinomatosis) 08/2004 - 12/2000
3	Neutropenia 11/2001 - 01/2000
3	Fever (Fevers) 11/2001 - 01/2000
2	Colorectal Neoplasms (Colorectal Cancer) 02/2006 - 09/2000
2	Hypersensitivity (Allergy) 12/2004 - 05/2001
1	Febrile Neutropenia 02/2006
1	Prostatic Neoplasms (Prostate Cancer) 08/2004
1	Hematologic Neoplasms (Hematological Malignancy) 05/2003
1	Vomiting 11/2001
1	Nausea 11/2001
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2000
1	Lung Neoplasms (Lung Cancer) 12/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2000
1	Glomerulonephritis 11/2000
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 11/2000

Drug/Important Bio-Agent (IBA)

3	Irinotecan (Camptosar)FDA LinkGeneric 02/2006 - 09/2000
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2004 - 11/2000
2	Growth InhibitorsIBA 08/2004 - 08/2001
2	RetinoidsIBA 08/2004 - 08/2001
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2004 - 08/2001
2	Cytotoxins (Cytolysins)IBA 05/2003 - 12/2000
2	irofulvenIBA 12/2000 - 12/2000
1	Messenger RNA (mRNA)IBA 02/2006
1	oblimersen (G3139)IBA 02/2006
1	Antisense OligonucleotidesIBA 02/2006
1	Proteins (Proteins, Gene)FDA Link 02/2006
1	AntigensIBA 12/2004
1	Monoclonal AntibodiesIBA 12/2004
1	mAb-AR20.5IBA 12/2004
1	4- ((4- (4- ethylphenyl)- 2,2- dimethyl- (2H)- thiochromen- 6- yl)ethynyl)benzoic acidIBA 08/2004
1	DNA (Deoxyribonucleic Acid)IBA 05/2003
1	bizelesinIBA 05/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2001
1	Tyrosine Kinase InhibitorsIBA 07/2001
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2001
1	ErbB Receptors (EGF Receptor)IBA 07/2001
1	benzimidazoleIBA 05/2001
1	7-methylthiomethylpaclitaxel (BMS 184476)IBA 05/2001
1	carbendazimIBA 05/2001
1	vesnarinoneIBA 12/2000
1	Gemcitabine FDA Link 12/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2000
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 12/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2000
1	ImmunoproteinsIBA 11/2000
1	CamptothecinIBA 09/2000
1	PlatinumIBA 09/2000
1	exatecan (DX 8951f)IBA 09/2000
1	Bay 12-9566IBA 01/2000
1	Fluorouracil (Carac)FDA LinkGeneric 01/2000
1	Matrix Metalloproteinases (MMPs)IBA 01/2000
1	Matrix Metalloproteinase InhibitorsIBA 01/2000
1	uridine triacetateIBA 01/2000

Therapy/Procedure

2	Intravenous Infusions 12/2004 - 01/2000
1	Therapeutics 05/2003
1	Premedication 05/2001